Autologous stem cell transplantation for acute myeloid leukemia in first remission.
about
Characterization of hemopoietic engraftment kinetics and development of secondary cytopenia in AML post auto-SCT and its correlation with survival outcome.Impact of polymorphisms in drug pathway genes on disease-free survival in adults with acute myeloid leukemia.Recombinant interleukin-2 in patients aged younger than 60 years with acute myeloid leukemia in first complete remission: results from Cancer and Leukemia Group B 19808P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemia.Autologous transplantation gives encouraging results for young adults with favorable-risk acute myeloid leukemia, but is not improved with gemtuzumab ozogamicinAutologous stem cell transplantation for acute myeloid leukemia.Impact of intensive PBSC mobilization therapy on outcomes following auto-SCT for non-Hodgkin's lymphoma.NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic maCurrent therapeutic strategies for acute myeloid leukaemia.Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation ResearchGranulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML).Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909.Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503).Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation.Mobilization of hematopoietic stem cells into the peripheral blood.Autologous transplant remains the preferred therapy for relapsed APL in CR2.Comparable outcomes between autologous and allogeneic transplant for adult acute myeloid leukemia in first CR.Autologous stem cell transplantation for advanced acute myeloid leukemia.Autologous peripheral blood stem cell transplantation in first remission adult acute myeloid leukaemia--an intention to treat analysis and comparison of outcome using a predictive model based on the MRC AML10 cohort.More efficient mobilisation of peripheral blood stem cells with HiDAC+AMSA+G-CSF than with mini-ICE+G-CSF in patients with AML.Auto-SCT for AML in second remission: CALGB study 9620.KIR and HLA genotypes predictive of low-affinity interactions are associated with lower relapse in autologous hematopoietic cell transplantation for acute myeloid leukemia.
P2860
Q33383210-E6A481DA-6A24-4A85-B06C-427777BED2E9Q33799305-F28F572A-FE2F-4B00-B463-73DBDCB1ABBAQ34069811-C6A29B72-7985-4100-8A14-194153050D20Q34124919-E02721F5-B067-413B-ADD1-7A0166C84E39Q34643306-522994EF-240E-48DC-8E6A-C952439419C7Q35029920-5AC37864-15CA-4878-82EA-766B28444296Q35122189-7F0FA481-00D3-4884-ABE8-47C560FE8735Q35213839-5B796CC9-F2EB-41EB-AB50-9411347B75DCQ35605318-008E0426-E131-4010-8EC8-BF683BDF154DQ36539598-D75CFB59-BF67-4C17-89D9-D936898DBD71Q36579065-FBCBD132-470A-441D-B6B8-4241C03C7B13Q37334588-DB9B9649-9EA0-4F79-B1FF-720C2A211493Q37474352-FC57E84B-DAAE-4702-BA8F-74860E20DC53Q37558778-455C5B64-16A7-4DF7-9DB5-F15788C1A719Q37723831-A6DDCB8B-C2E5-45B8-996A-FC04594EA0A3Q37810088-B537B9A5-2F1C-4965-9147-4500EEC3211FQ39843411-078E4C02-9650-4551-BF6B-A4F8291E1DFEQ40064058-00E022BD-1C6D-431B-A62A-D45BBAC69560Q43918950-7E91EEC0-B929-456B-9AE0-62DA24824778Q44440141-55D6C384-4D0F-4BAE-A43D-82E990F1BDA6Q44675133-13B6BDF6-AE1A-426A-AC0E-A3509CDFD3C1Q46086701-E819B267-CA58-4274-8CCC-E5ABB28E3BDDQ46269995-81FDA562-10E2-42E1-8EB2-3B4174661D18
P2860
Autologous stem cell transplantation for acute myeloid leukemia in first remission.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Autologous stem cell transplantation for acute myeloid leukemia in first remission.
@en
type
label
Autologous stem cell transplantation for acute myeloid leukemia in first remission.
@en
prefLabel
Autologous stem cell transplantation for acute myeloid leukemia in first remission.
@en
P2093
P1476
Autologous stem cell transplantation for acute myeloid leukemia in first remission.
@en
P2093
P356
10.1016/S1083-8791(00)70052-8
P577
2000-01-01T00:00:00Z